Our Laboratory

Established since 2007, Synapse Laboratory has been providing medical testing services including DNA / RNA tests and genetic testing for newborns.

Our state-of-the-art laboratory for newborn screening was established using laboratory instruments from Sciex and Perkin Elmer, which are the best in the industry. The filter paper used to collect the blood sample is manufactured by Whatman (a GE Healthcare company) to maintain sample integrity.

As the first and only private newborn screening laboratory in Malaysia, it is our aim to bring this leading-edge technology to physicians and parents at a reasonable price to improve infant health outcomes.

Synapse Laboratory participates in the U.S. Centers for Disease Control (CDC)’s Newborn Screening Quality Assurance Program (NSQAP), a quality control program used by over 650 newborn screening laboratories across the world to assure the accuracy of newborn screening test results.

Through our partnership with internationally accredited laboratory and highly experienced experts in newborn screening, we shall provide advisory support to physicians and parents for treatment and follow up actions.

Our team of highly experienced experts in newborn screening comprises of scientists, pathologists, clinicians and genetic counsellors. With quality results and interpretation, we provide holistic support to physicians and parents for treatment and follow up actions.

BabySafe Newborn Screening

BabySafe screens newborn babies for Inherited Metabolic Diseases (IEM). IEM are genetic diseases caused by defective proteins, which are essential for metabolic reactions.

The development and advancement of key technologies such as tandem mass spectrometry allows for effective detection of metabolic disorders, some of which are potentially fatal conditions that are not apparent at birth.

Newborn screening (NBS) programs are an integral part of healthcare services in countries around the world. Such programs are implemented in countries such as the United States, United Kingdom, Australia and Singapore to list a few.

Early detection of these diseases is important for early treatment and prevention of severe health problems such as mental retardation or even mortality.

BabySafe screens newborn babies for Inherited Metabolic Diseases (IEM). IEM are genetic diseases caused by defective proteins, which are essential for metabolic reactions.
Liquid chromatography–mass spectrometry (LC-MS) is an analytical chemistry technique which is widely used to analyze biochemical, organic, and inorganic compounds.

Our success resides in the dedication and commitment of our workforce.

Technology Partners

Synapse Laboratory partners with market-leaders in newborn screening and facilitate innovative new technologies to offer unique screening and diagnostic solutions.